G. Klus

发表

Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements.

Z. Szallasi, I. Kohane, B. Mecham, 2004, Nucleic acids research.

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

Z. Szallasi, I. Csabai, Yonghong Xiao, 2018, British Journal of Cancer.

Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.

G. Klus, E. Wilson, J. A. Kemppainen, 1996, Cancer research.

Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer.

Z. Szallasi, S. Sukumar, G. Klus, 2001, International journal of oncology.

17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha).

G. Klus, Katsuya Kato, A. Brodie, 1997, Journal of medicinal chemistry.

Nucleophilic vinylic “addition-elimination” substitution reaction of 3β-acetoxy-17-chloro-16-formylandrosta-5,16-diene: A novel and general route to 17-substituted steroids. Part 1 - synthesis of novel 17-azolyl-Δ16 steroids; inhibitors of 17α-hydroxylase/17, 20-lyase (17α-lyase)

G. Klus, V. Njar, Angela Brodie, 1996 .

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Z. Szallasi, I. Csabai, G. Klus, 2023, bioRxiv.

Near‐tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness

G. Klus, T. Ried, D. Cimini, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles

Z. Szallasi, I. Csabai, G. Klus, 2021, medRxiv.

Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line

Z. Szallasi, G. Klus, M. Augustus, 2004, Cancer Research.

Advances in Brief Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line

Z. Szallasi, G. Klus, M. Augustus, 2004 .

Synthesis of novel 21-trifluoropregnane steroids: Inhibitors of 17α-hydroxylase/17,20-lyase (17α-lyase)

G. Klus, V. Njar, A. Brodie, 1997, Steroids.

Synthesis and in vitro activity of some epimeric 20α-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17α-hydroxylase/c 17,20 -lyase and 5α-reductase

G. Klus, Katsuya Kato, A. Brodie, 1998 .

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

Z. Szallasi, I. Csabai, Yonghong Xiao, 2018, British Journal of Cancer.